ST Pharm Co.,Ltd. (KOSDAQ:237690)
75,000
+2,900 (4.02%)
Apr 1, 2025, 3:30 PM KST
ST Pharm Revenue
ST Pharm had revenue of 61.70B KRW in the quarter ending September 30, 2024, with 10.29% growth. This brings the company's revenue in the last twelve months to 278.64B, up 5.24% year-over-year. In the year 2023, ST Pharm had annual revenue of 284.99B with 14.31% growth.
Revenue (ttm)
278.64B
Revenue Growth
+5.24%
P/S Ratio
5.34
Revenue / Employee
417.94M
Employees
655
Market Cap
1,511.47B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |